CG ONCOLOGY, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.6 USD | +6.83% |
|
-18.63% | 0.00% |
| 01:59pm | Goldman Sachs Upgrades CG Oncology to Buy From Neutral With $50 Price Target | MT |
| May. 09 | CG Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar CG Oncology, Inc.
358055e53d329eeea4b29368c2b0778.3uQSOf6fmP9EPbZoBJHgHNfy-iaAzV7Wq1lndEi3FrI.6d1GUav70tIHD_5eZ96Df5aAg1_It2iYhmkUPzjuIoCX1SVap_HxjjQE3Q~e0eecff7fb9b67e2f61ca19b48dcd7c5
Upcoming events on CG Oncology, Inc.
No events available
Past events on CG Oncology, Inc.
| 2024-05-09 08:00 am | Q1 2024 Earnings Release |
| 2024-05-05 11:56 am | American Urological Association Meeting - BOND-003 |
| 2024-05-05 11:24 am | American Urological Association Meeting - PIVOT-006 |
| 2024-05-03 11:23 am | American Urological Association Meeting - Abstract Number : 24-11358 |
| 2024-01-24 | ASCO Genitourinary Cancers Symposium |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,10 - | 1,66 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -55,4 -63,5 12.68% | -95,4 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -55,4 -56,7 2.18% | -100 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -48,6 -46,2 -5.11% | -96,2 |
|
Net income Million USD | Released Forecast Spread | -35,4 | -48,6 -56,6 14.12% | -88,3 |
|
EPS USD | Released Forecast Spread | -11,7 | -15,7 -1,19 -1211.46% | -1,71 |
| Announcement Date | 27/10/23 | 26/03/24 | - |
Quarterly results
| Fiscal Period | December | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,53 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -18,9 -45,6 58.46% | -22,5 -18,1 -24.41% | -22,8 | -25,7 | -27,4 | -29,7 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -16,9 -15,8 -7.16% | -24,9 | -27,1 | -29,5 | |||
|
Net income Million USD | Released Forecast Spread | -16,9 -15,8 -7.16% | -24,9 | -27,1 | -29,5 | |||
|
EPS USD | Released Forecast Spread | -0,35 | -0,36 -0,37 2.7% | -0,41 | -0,45 | -0,48 | ||
| Announcement Date | 26/03/24 | 09/05/24 | - | - | - | - | - |
| 2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 2024-05-15 | REPLIMUNE GROUP, INC.: Q4 2024 Earnings Release (Projected) |
| 2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 2024-05-20 | ALVOTECH: Q1 2024 Earnings Release |
| 2024-05-21 | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
| 2024-05-21 | EXSCIENTIA PLC: Q1 2024 Earnings Release (Projected) |
| 2024-05-21 | EVOTEC SE: Q1 2024 Earnings Release |
| 2024-06-30 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
| 2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for CG Oncology, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CGON Stock
- Calendar CG Oncology, Inc.
